KRATOM GORILLAS LLC Trademark

Trademark Overview


On Friday, September 6, 2024, a trademark application was filed for KRATOM GORILLAS LLC with the United States Patent and Trademark Office. The USPTO has given the KRATOM GORILLAS LLC trademark a serial number of 98738085. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, March 18, 2025. This trademark is owned by Saba Ayesha. The KRATOM GORILLAS LLC trademark is filed in the Pharmaceutical Products category with the following description:

Kratom is a tropical tree native to Southeast Asia. Consumption of its leaves produces both stimulant effects (in low doses) and sedative effects (in high doses), and can lead to psychotic symptoms, and psychological and physiological dependence. Kratom leaves contain two major psychoactive ingredients (mitragynine and 7~hydroxymytragynine). These leaves are crushed and then smoked, brewed with tea, or placed into gel capsules. Kratom has a long history of use in Southeast Asia, where it is commonly known as thang, kakuam, thom, ketum, and biak. What are the effects~ At low doses, kratom produces stimulant effects with users reporting increased alertness, physical energy, and talkativeness. At high doses, users experience sedative effects. Kratom consumption can lead to addiction. Several cases of psychosis resulting from use of kratom have been reported, where individuals addicted to kratom exhibited psychotic symptoms, including hallucinations, delusion, and confusion. What does it d...
kratom gorillas llc

General Information


Serial Number98738085
Word MarkKRATOM GORILLAS LLC
Filing DateFriday, September 6, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesKratom is a tropical tree native to Southeast Asia. Consumption of its leaves produces both stimulant effects (in low doses) and sedative effects (in high doses), and can lead to psychotic symptoms, and psychological and physiological dependence. Kratom leaves contain two major psychoactive ingredients (mitragynine and 7~hydroxymytragynine). These leaves are crushed and then smoked, brewed with tea, or placed into gel capsules. Kratom has a long history of use in Southeast Asia, where it is commonly known as thang, kakuam, thom, ketum, and biak. What are the effects~ At low doses, kratom produces stimulant effects with users reporting increased alertness, physical energy, and talkativeness. At high doses, users experience sedative effects. Kratom consumption can lead to addiction. Several cases of psychosis resulting from use of kratom have been reported, where individuals addicted to kratom exhibited psychotic symptoms, including hallucinations, delusion, and confusion. What does it do to the body~ Kratom's effects on the body include nausea, itching, sweating, dry mouth, constipation, increased urination, tachycardia, vomiting, drowsiness, and loss of appetite.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 6, 2024
Primary Code005
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

Trademark Owner History


Party NameSaba Ayesha
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRichmond, TX 77407

Trademark Events


Event DateEvent Description
Friday, September 6, 2024NEW APPLICATION ENTERED
Monday, March 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 18, 2025ASSIGNED TO EXAMINER